Evaluation of applicability of the online version of HADS-D for depression phenotype screening in the general population
AA Kibitov, AS Rakitko, ED Kasyanov, GV Rukavishnikov, KA Kozlova, VV Ilinsky, NG Neznanov, GE Mazo, AO Kibitov
doi: https://doi.org/10.1101/2020.10.16.20213843
AA Kibitov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
AS Rakitko
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
2Genotek Ltd., Moscow, Russian Federation
ED Kasyanov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
GV Rukavishnikov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
KA Kozlova
3Lomonosov Moscow State University, Moscow, Russian Federation
VV Ilinsky
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
2Genotek Ltd., Moscow, Russian Federation
NG Neznanov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
4First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russian Federation
GE Mazo
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
AO Kibitov
1V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russian Federation
5Serbsky National Medical Research Center on Psychiatry and Addictions, Moscow, Russian Federation

Article usage
Posted October 20, 2020.
Evaluation of applicability of the online version of HADS-D for depression phenotype screening in the general population
AA Kibitov, AS Rakitko, ED Kasyanov, GV Rukavishnikov, KA Kozlova, VV Ilinsky, NG Neznanov, GE Mazo, AO Kibitov
medRxiv 2020.10.16.20213843; doi: https://doi.org/10.1101/2020.10.16.20213843
Evaluation of applicability of the online version of HADS-D for depression phenotype screening in the general population
AA Kibitov, AS Rakitko, ED Kasyanov, GV Rukavishnikov, KA Kozlova, VV Ilinsky, NG Neznanov, GE Mazo, AO Kibitov
medRxiv 2020.10.16.20213843; doi: https://doi.org/10.1101/2020.10.16.20213843
Subject Area
Subject Areas
- Addiction Medicine (227)
- Allergy and Immunology (500)
- Anesthesia (110)
- Cardiovascular Medicine (1230)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10005)
- Gastroenterology (497)
- Genetic and Genomic Medicine (2445)
- Geriatric Medicine (236)
- Health Economics (479)
- Health Informatics (1635)
- Health Policy (751)
- Hematology (248)
- HIV/AIDS (531)
- Medical Education (251)
- Medical Ethics (74)
- Nephrology (267)
- Neurology (2273)
- Nursing (139)
- Nutrition (350)
- Oncology (1244)
- Ophthalmology (375)
- Orthopedics (133)
- Otolaryngology (226)
- Pain Medicine (154)
- Palliative Medicine (50)
- Pathology (324)
- Pediatrics (729)
- Primary Care Research (282)
- Public and Global Health (4824)
- Radiology and Imaging (833)
- Respiratory Medicine (650)
- Rheumatology (283)
- Sports Medicine (225)
- Surgery (266)
- Toxicology (44)
- Transplantation (124)
- Urology (99)